Yearly Archives: 2025

/2025

MPs find medicines shortages now a systemic threat to NHS patient care

A new report from the All-Party Parliamentary Group (APPG) on Pharmacy calls for urgent reforms to medicines supply, after describing shortages as a “permanent and escalating feature” of the healthcare system. Published today, the report on an APPG inquiry into the issue concludes that shortages have become a constant and growing threat to NHS care [...]

The post MPs find medicines shortages now a systemic threat to NHS patient care appeared first on Community Pharmacy England.

By |July 8th, 2025|Lexpos News|Comments Off on MPs find medicines shortages now a systemic threat to NHS patient care

Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution (Laboratoires Théa)

MHRA Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution (Laboratoires Théa) Drug alert number: EL(25)A/34 Date issued: 07 July 2025 Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the risk of microbial contamination of the [...]

The post Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution (Laboratoires Théa) appeared first on Community Pharmacy England.

By |July 7th, 2025|Lexpos News|Comments Off on Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution (Laboratoires Théa)

Reminder: GLP-1 receptor agonists interactions with oral contraception – safety guidance

Pharmacy owners providing the Pharmacy Contraception Service are reminded that the Faculty of Sexual & Reproductive Healthcare (FSRH) advises that individuals use contraception whilst using Glucagon-like peptide-1 (GLP-1) agonists, with additional advice for those using tirzepatide. The statement from the FSRH can be found at: FSRH statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception (Feb [...]

The post Reminder: GLP-1 receptor agonists interactions with oral contraception – safety guidance appeared first on Community Pharmacy England.

By |July 7th, 2025|Lexpos News|Comments Off on Reminder: GLP-1 receptor agonists interactions with oral contraception – safety guidance

London Pharmacy Owners: Book on your local Future of Pharmacy workshop

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across London are invited to ‘Future of Pharmacy’ workshop event to discuss the potential [...]

The post London Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

By |July 7th, 2025|Lexpos News|Comments Off on London Pharmacy Owners: Book on your local Future of Pharmacy workshop

New shortened claim journey for DMS is live

The new streamlined process for making claims for the Discharge Medicines Service (DMS) has gone live today (6th July 2025). The new process, which has been agreed following feedback about the previous lengthy process from Community Pharmacy England, should be used to claim for any activity for DMS that has been completed since 1st July [...]

The post New shortened claim journey for DMS is live appeared first on Community Pharmacy England.

By |July 6th, 2025|Lexpos News|Comments Off on New shortened claim journey for DMS is live